Cargando…

A 52‐week randomized controlled trial of ipragliflozin or sitagliptin in type 2 diabetes combined with metformin: The N‐ISM study

AIM: To compare the long‐term efficacy of sodium‐glucose co‐transporter‐2 inhibitors and dipeptidyl peptidase‐4 inhibitors as second‐line drugs after metformin for patients not at high risk of atherosclerotic cardiovascular disease (ASCVD). MATERIALS AND METHODS: In a 52‐week randomized open‐label t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitazawa, Masaru, Katagiri, Takashi, Suzuki, Hiromi, Matsunaga, Satoshi, H Yamada, Mayuko, Ikarashi, Tomoo, Yamamoto, Masahiko, Furukawa, Kazuo, Iwanaga, Midori, Hatta, Mariko, Fujihara, Kazuya, Yamada, Takaho, Tanaka, Shiro, Sone, Hirohito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898334/ https://www.ncbi.nlm.nih.gov/pubmed/33416200 http://dx.doi.org/10.1111/dom.14288

Ejemplares similares

Impact of prior cerebrovascular disease and glucose status on incident cerebrovascular disease in Japanese
por: Oe, Momoko, et al.
Publicado: (2021)

Machine learning approach to predict body weight in adults
por: Fujihara, Kazuya, et al.
Publicado: (2023)

Rates and risk factors for amputation in people with diabetes in Japan: a historical cohort study using a nationwide claims database
por: Kaneko, Masanori, et al.
Publicado: (2021)

Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex
por: Matsubayashi, Yasuhiro, et al.
Publicado: (2022)

Diabetes mellitus and risk of new‐onset and recurrent heart failure: a systematic review and meta‐analysis
por: Kodama, Satoru, et al.
Publicado: (2020)

Ability of Current Machine Learning Algorithms to Predict and Detect Hypoglycemia in Patients With Diabetes Mellitus: Meta-analysis
por: Kodama, Satoru, et al.
Publicado: (2021)

Glycosuria medicated with ipragliflozin and nifedipine or ipragliflozin and candesartan: a case report
por: Okada, Shuichi, et al.
Publicado: (2014)

Comparison of baseline characteristics and clinical course in Japanese patients with type 2 diabetes among whom different types of oral hypoglycemic agents were chosen by diabetes specialists as initial monotherapy (JDDM 42)
por: Fujihara, Kazuya, et al.
Publicado: (2017)

Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin
por: Kaku, Kohei, et al.
Publicado: (2021)

Association of estimated plasma volume and weight loss after long‐term administration and subsequent discontinuation of the sodium‐glucose cotransporter‐2 inhibitor tofogliflozin
por: Matsubayashi, Yasuhiro, et al.
Publicado: (2021)

Predictors of haemoglobin levels and of changes in these levels, focusing on anaemia and polycythaemia after administration of the sodium‐glucose cotransporter‐2 inhibitor tofogliflozin
por: Matsubayashi, Yasuhiro, et al.
Publicado: (2022)

Predictive ability of current machine learning algorithms for type 2 diabetes mellitus: A meta‐analysis
por: Kodama, Satoru, et al.
Publicado: (2022)

Combination of diabetes mellitus and lack of habitual physical activity is a risk factor for functional disability in Japanese
por: Fujihara, Kazuya, et al.
Publicado: (2020)

Comparison of clinical characteristics in patients with type 2 diabetes among whom different antihyperglycemic agents were prescribed as monotherapy or combination therapy by diabetes specialists
por: Fujihara, Kazuya, et al.
Publicado: (2015)

A randomized, placebo‐controlled trial to assess the efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes and inadequate glycaemic control on ipragliflozin
por: Seino, Yutaka, et al.
Publicado: (2021)

Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model
por: Morishita, Asahiro, et al.
Publicado: (2022)

Black Looks ... at 'Isms'
por: Black, Douglas
Publicado: (1992)

Buffalo as an ISM Center
Publicado: (1900)

Efficacy and safety of ipragliflozin as an add‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial
por: Han, Kyung‐Ah, et al.
Publicado: (2018)

simpleISM—A straight forward guide to upgrade from confocal to ISM
por: Goswami, Monalisa, et al.
Publicado: (2022)

Family Support for Medical Nutritional Therapy and Dietary Intake among Japanese with Type 2 Diabetes (JDDM 56)
por: Horikawa, Chika, et al.
Publicado: (2020)

Association Between Physical Activity and Risk of All-Cause Mortality and Cardiovascular Disease in Patients With Diabetes: A meta-analysis
por: Kodama, Satoru, et al.
Publicado: (2013)

Reversible brain atrophy and cognitive impairment in an adolescent Japanese patient with primary adrenal Cushing’s syndrome
por: Ohara, Nobumasa, et al.
Publicado: (2014)

Modern Isms and Ologies, (Poetical)
Publicado: (1874)

The Cure of Cancer by Mattei-ism
por: Boncher, M. Louis
Publicado: (1892)

A Third “Ism”: Ageism
por: DeMaria, Anthony
Publicado: (2023)

Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus
por: Fujihara, Kazuya, et al.
Publicado: (2018)

Machine Learning Approach to Drug Treatment Strategy for Diabetes Care
por: Fujihara, Kazuya, et al.
Publicado: (2023)

Comparing the efficacy of apple peels and a sodium-glucose cotransporter 2 inhibitor (ipragliflozin) on interstitial glucose levels: A pilot case study
por: Okada, Junichi, et al.
Publicado: (2020)

Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease
por: Miyake, Teruki, et al.
Publicado: (2018)

Machine Learning Approach to Decision Making for Insulin Initiation in Japanese Patients With Type 2 Diabetes (JDDM 58): Model Development and Validation Study
por: Fujihara, Kazuya, et al.
Publicado: (2021)

Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling
por: Suga, Takayoshi, et al.
Publicado: (2020)

Impact of a history of cardiovascular disease and physical activity habits on the incidence of functional disability
por: Kodera, Remi, et al.
Publicado: (2023)

Association of increased hepatic insulin clearance and change in serum triglycerides or β‐hydroxybutyrate concentration via the sodium/glucose‐cotransporter 2 inhibitor tofogliflozin
por: Matsubayashi, Yasuhiro, et al.
Publicado: (2020)

Workshop in the Neutral ISM in Starburst Galaxies
Publicado: (2003)

Lobelia—Ism—Its Prospects and Policy
por: Smith, J. Dickson
Publicado: (1860)

Combined Effects of Energy Intake and Physical Activity on Obesity in Japanese Patients with Type 2 Diabetes (JDDM 50): A Cross-Sectional Study
por: Hatta, Mariko, et al.
Publicado: (2019)

Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME‐V study)
por: Koshizaka, Masaya, et al.
Publicado: (2020)

Retrospective cohort study to examine the association between serum amylase and the incidence of type 2 diabetes mellitus, Toranomon Hospital Health Management Center Study 23 (TOPICS 23)
por: Ikeda, Izumi, et al.
Publicado: (2023)

Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD
por: Takahashi, Hirokazu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8jdht5dvpnocjdl7jo8f12d4la